Back to 
Danske Bank A/S
Danske Bank A/S
ADMA
Showing 7 of 9 quarters
Position history for Danske Bank A/S's holdings in ADMA Biologics Inc
No. Danske Bank exited its ADMA (ADMA Biologics) position in Q1 2026. Its Q4 2025 13F listed 500 shares worth $9,120. Danske Bank already held ADMA in its Q1 2024 13F, the earliest on record, and held it in 8 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1.5M
Total Shares Change
-75,696
Quarter-by-Quarter History